Last reviewed · How we verify
Sculptra
At a glance
| Generic name | Sculptra |
|---|---|
| Also known as | Poly-L-Lactic acid fillers |
| Sponsor | Massachusetts General Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging (NA)
- Post-Menopause Skin Rejuvenation Study (PHASE4)
- Randomized Trial of Combination Treatment With Sofwave and Sculptra (PHASE4)
- A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages (NA)
- To Evaluate the Safety and Efficacy of Poly-L-lactic Acid Implants for the Correction of Nasolabial Folds (NA)
- Safety and Effectiveness of Sculptra 011611 for Improvement in Appearance of Gluteal Skin Irregularities (NA)
- Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device (PHASE4)
- Assess Impact of Poly-L-lactic Acid on GLP1 Subjects (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sculptra CI brief — competitive landscape report
- Sculptra updates RSS · CI watch RSS
- Massachusetts General Hospital portfolio CI